Table 2.

Clinicopathological parameters in patients stratified by psoriasis subtype

	Controls	Cases	p value
PsV
Sex (male/female)	482/212	241/106	1.0000
Age at enrollment	43.11 ± 14.24	43.11 ± 14.23	> 0.9999
WBC	6.30 ± 1.60	6.84 ± 1.98	< 0.0001
Lymphocyte	2.14 ± 0.61	1.90 ± 0.66	< 0.0001
Neutrophil	3.61 ± 1.18	4.21 ± 1.62	< 0.0001
RBC	4.94 ± 0.43	4.62 ± 0.53	< 0.0001
Hb	149.10 ± 13.47	143.18 ± 14.54	< 0.0001
PLT	233.77 ± 51.86	233.35 ± 68.48	0.5899
NLR	1.78 ± 0.68	2.41 ± 1.21	< 0.0001
PLR	116.41 ± 37.08	134.03 ± 56.82	< 0.0001
GPP
Sex (male/female)	40/34	20/17	1.0000
Age at enrollment	41.14 ± 14.25	41.24 ± 14.16	> 0.9999
WBC	6.50 ± 1.61	9.53 ± 2.99	< 0.0001
Lymphocyte	2.15 ± 0.57	1.52 ± 0.56	< 0.0001
Neutrophil	3.77 ± 1.19	7.10 ± 2.88	< 0.0001
RBC	4.93 ± 0.45	4.27 ± 0.37	< 0.0001
Hb	146.24 ± 13.28	128.86 ± 14.32	< 0.0001
PLT	240.41 ± 45.93	289.95 ± 102.14	0.0311
NLR	1.82 ± 0.61	5.90 ± 5.15	< 0.0001
PLR	118.29 ± 33.38	221.82 ± 126.01	< 0.0001
PsE
Sex (male/female)	78/12	39/6	1.0000
Age at enrollment	49.47 ± 13.80	49.47 ± 13.88	> 0.9999
WBC	6.42 ± 1.69	7.14 ± 2.02	0.0448
Lymphocyte	2.16 ± 0.59	1.61 ± 0.45	< 0.0001
Neutrophil	3.69 ± 1.22	4.57 ± 1.72	0.0023
RBC	4.98 ± 0.41	4.22 ± 0.54	< 0.0001
Hb	151.40 ± 10.71	129.13 ± 15.27	< 0.0001
PLT	224.77 ± 48.53	271.02 ± 78.07	0.0003
NLR	1.77 ± 0.59	3.02 ± 1.34	< 0.0001
PLR	110.12 ± 33.51	182.99 ± 82.45	< 0.0001
PsA
Sex (male/female)	30/20	15/10	1.0000
Age at enrollment	43.04 ± 14.16	43.04 ± 14.31	> 0.9999
WBC	5.97 ± 1.46	7.71 ± 2.68	0.0033
Lymphocyte	1.92 ± 0.56	1.59 ± 0.42	0.0092
Neutrophil	3.56 ± 1.06	5.38 ± 2.38	0.0003
RBC	4.84 ± 0.39	4.12 ± 0.57	<0.0001
Hb	146.36 ± 13.00	121.40 ± 21.49	<0.0001
PLT	214.42 ± 38.47	311.08 ± 134.54	<0.0001
NLR	1.96 ± 0.71	3.49 ± 1.56	<0.0001
PLR	119.44 ± 35.93	199.06 ± 74.24	<0.0001